Table 1. Study populations.
| ERF | MICROS | NSPHS | ORCADES | VIS | |
| N (4034) | 800 | 1086 | 654 | 714 | 780 |
| % Female (56.4) | 60.13 | 56.63 | 52.75 | 53.36 | 57.94 |
| Age | 49.65 (15.20) | 45.26 (16.08) | 46.98 (20.70) | 53.59 (15.71) | 56.55 (15.36) |
| Total SPM | 532.21 (109.39) | 587.03 (114.19) | 516.98 (121.98) | 468.25 (96.4) | 499.01 (105.26) |
| Total PC | 2198.55 (444.36) | 2527.88 (457.25) | 2249.18 (493.67) | 1941.73 (372.96) | 2066.56 (427.91) |
| Total PLPE | 52.68 (14.91) | 58.21 (17.05) | 62.28 (24.28) | 42.15 (13.16) | 55.60 (15.39) |
| Total PE | 37.22 (16.69) | 37.15 (18.12) | 20.58 (7.25) | 25.02 (11.19) | 34.34 (14.55) |
| Total CER | 8.45 (1.95) | 9.26 (2.12) | 9.30 (2.52) | 7.12 (1.83) | 9.05 (2.23) |
Values for age and lipid concentrations are presented as mean (standard deviation).